Search research articles
Contact Us
Filters
Showing results (81-90 of 180) with videos related to
Page
of 18
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
APOBEC3A drives metastasis of high-grade serous ovarian cancer by altering epithelial-to-mesenchymal transition
Jessica M Devenport, Thi Tran, Brooke R Harris, et al.
Cancer Research
|
October 10, 2022
Cell Competition in Carcinogenesis
Esha Madan, António M Palma, Vignesh Vudatha, et al.
Stem Cell Reports
|
January 11, 2019
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs
Anil Belur Nagaraj, Peronne Joseph, Erin Ponting, et al.
JCI Insight
|
September 13, 2016
Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors
Kevin M Elias, Megan M Emori, Thomas Westerling, et al.
JCI Insight
|
March 10, 2025
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition
Jessica M Devenport, Thi Tran, Brooke R Harris, et al.
Scientific Reports
|
December 6, 2025
Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induces cell death and inhibits growth of high grade serous ovarian carcinoma
Kranthi Kumar Chougoni, Jacqueline West, Nicholette St Martin, et al.
Cancer Research
|
December 20, 2018
Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer
Jagmohan Hooda, Marián Novak, Matthew P Salomon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 23, 2021
Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models
Laura J Mauro, Megan I Seibel, Caroline H Diep, et al.
Communications Biology
|
December 12, 2022
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
Kai Doberstein, Rebecca Spivak, Hunter D Reavis, et al.
Molecular Cancer Therapeutics
|
January 26, 2019
Combined MEK and BCL-2/X<sub>L</sub> Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
Claudia Iavarone, Ioannis K Zervantonakis, Laura M Selfors, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 180) with videos related to
Sort By:
Page
of 18
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
APOBEC3A drives metastasis of high-grade serous ovarian cancer by altering epithelial-to-mesenchymal transition
Jessica M Devenport, Thi Tran, Brooke R Harris, et al.
Cancer Research
|
October 10, 2022
Cell Competition in Carcinogenesis
Esha Madan, António M Palma, Vignesh Vudatha, et al.
Stem Cell Reports
|
January 11, 2019
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs
Anil Belur Nagaraj, Peronne Joseph, Erin Ponting, et al.
JCI Insight
|
September 13, 2016
Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors
Kevin M Elias, Megan M Emori, Thomas Westerling, et al.
JCI Insight
|
March 10, 2025
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition
Jessica M Devenport, Thi Tran, Brooke R Harris, et al.
Scientific Reports
|
December 6, 2025
Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induces cell death and inhibits growth of high grade serous ovarian carcinoma
Kranthi Kumar Chougoni, Jacqueline West, Nicholette St Martin, et al.
Cancer Research
|
December 20, 2018
Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer
Jagmohan Hooda, Marián Novak, Matthew P Salomon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 23, 2021
Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models
Laura J Mauro, Megan I Seibel, Caroline H Diep, et al.
Communications Biology
|
December 12, 2022
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
Kai Doberstein, Rebecca Spivak, Hunter D Reavis, et al.
Molecular Cancer Therapeutics
|
January 26, 2019
Combined MEK and BCL-2/X<sub>L</sub> Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
Claudia Iavarone, Ioannis K Zervantonakis, Laura M Selfors, et al.
Page
of 18